Produktinformationen
Kinami Health gewährleistet eine schnelle und sichere Lieferung für Kliniken, Krankenhäuser und Kosmetiker. Profitieren Sie von schnellem und zuverlässigem Versand, damit Ihre Bestellungen schnell eintreffen. Unsere sichere Verpackung garantiert, dass die Produkte unbeschädigt und gebrauchsfertig bei Ihnen ankommen.
Wir liefern ausschließlich originale medizinische und ästhetische Produkte direkt von vertrauenswürdigen Herstellern. Jeder Artikel wird einer Qualitätskontrolle unterzogen, um Sicherheit, Wirksamkeit und Einhaltung von Industriestandards zu gewährleisten. Erhalten Sie Premiumprodukte zu wettbewerbsfähigen Preisen.
Unsere Vertriebsmitarbeiter helfen Ihnen, die optimale Lösung für Ihre Praxis zu finden. Ob Produktempfehlungen, Mengenrabatte oder Unterstützung bei der Bestellung – wir sind nur einen Anruf oder eine Nachricht entfernt.
Treue Kunden genießen bevorzugten Service, frühzeitigen Zugang zu neuen Produkten und exklusive Rabatte. Wir schätzen Ihr Geschäft und stellen sicher, dass Sie die besten Angebote und die beste Unterstützung erhalten, um Ihr Unternehmen weiterzuentwickeln.
CROMA PhilArt NEXT is an injectable gel formulated with PN-HPT® (Polynucleotide High Purification Technology) and hyaluronic acid. This premium dermal product leverages advanced molecular science to stimulate natural collagen synthesis and enhance cellular regeneration.
The CROMA PhilArt NEXT formulation delivers 20mg of polynucleotides and 20mg of hyaluronic acid per 2 ml pre-filled syringe, providing medical professionals with a precise solution for aesthetic procedures.
Professional administration of CROMA PhilArt NEXT requires precise injection techniques and appropriate dosage protocols. The recommended dosage involves administering 1-2 ml of PhilArt per treatment session, distributed across the targeted areas using intradermal injection techniques.
Treatment protocols typically involve three to four sessions spaced 14–21 days apart for optimal results. Medical practitioners should utilize serial puncture or linear retrograde injection techniques with appropriate spacing between injection points. Maintenance treatments with CROMA are recommended every 4–6 months to sustain therapeutic benefits.
CROMA PhilArt NEXT contains precisely formulated active ingredients designed for optimal therapeutic efficacy. The primary components include 20mg of PN-HPT® polynucleotides and 20mg of hyaluronic acid per 2ml formulation.
The polynucleotide component utilizes advanced purification technology, derived from European freshwater fish sources meeting pharmaceutical-grade standards. These biocompatible molecules stimulate cellular regeneration and promote natural repair mechanisms within dermal tissues. The formulation excludes lidocaine, making it suitable for patients with local anesthetic sensitivities.
Proper storage of CROMA PhilArt NEXT ensures product integrity and therapeutic efficacy throughout its shelf life. The products require storage at controlled temperatures between 2 °C and 25°C to maintain formulation stability and potency.
Healthcare facilities must protect products from direct sunlight and extreme temperature fluctuations. Freezing temperatures can damage the polynucleotides and hyaluronic acid components, compromising therapeutic effectiveness.
CROMA PhilArt NEXT has specific contraindications that practitioners must evaluate before initiating treatment:
Healthcare professionals must observe specific precautions during administration to ensure patient safety and optimal therapeutic outcomes. Strict aseptic techniques are mandatory during treatment procedures to prevent infection.
Patients on anticoagulant medications may experience an increased risk following injections. Medical practitioners should assess bleeding risk and consider appropriate precautions when medically appropriate.
CROMA Pharma manufactures PhilArt NEXT under stringent pharmaceutical quality standards, ensuring consistent product quality and therapeutic efficacy. The product is certified with CE marking, indicating compliance with relevant medical device regulations and safety standards. Each unit includes batch coding for complete traceability and quality control purposes.
When healthcare professionals buy CROMA PhilArt NEXT or order CROMA PhilArt NEXT for their medical practices, they invest in proven regenerative technology backed by extensive clinical research and pharmaceutical-grade manufacturing standards.
Kinami Health prides itself on supplying genuine, high-quality medical injectables and supplies to hospitals, medical clinics, and licensed medical professionals around the world.
Pay easily with trusted providers
Links
Working Hours
Monday – Saturday
7 AM – 11 PM (CET)
Contact
UK: +44 7488 890499
Spain: +34 518 89 82 11
HongKong: +852 5808 0345
Email: [email protected]
Our Location
Room 4, Office 18, Block 19, Vicenti Building,
Triq Id-Dejqa, Valletta, VLT 1431, Malta
**We guarantee that you will receive your order. If your parcel does not make it to your doorstep, we will send you the order free of charge.
*** Information on this site is provided for informational purposes only. The use of some of the products included on this website should always be supervised and in any case be prescribed by a physician. It is not meant to substitute for the advice provided by your own physician or other medical professional. If you have or suspect that you have a medical problem, promptly contact your health care provider. The products must be used according to the information provided by manufacturers printed in brochures and on the packaging of the products. You should carefully read all product packaging, and contact the manufacturer with any questions before using a product.
*All products found on Kinamihealth.com are 100% authentic. The brands are trademarked and owned by their original manufacturers. Please note that this website is not affiliated with these manufacturers. Product packaging may not look exactly as seen here.
© 2025. All rights reserved
